Raman Venkataramanan
University of Pittsburgh
409 Papers
3.6K Citations
Raman Venkataramanan is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Medicine & Transplantation. The author has an hindex of 63, co-authored 390 publications. Previous affiliations of Raman Venkataramanan include Boston Children's Hospital & Center for Drug Evaluation and Research.
Chat about Author
Papers
Pharmacokinetics of orally administered ritodrine.
TL;DR: In this paper, the authors compared ritodrine kinetics in pregnant and non-pregnant women, evaluate the effect of feeding on ritodorine absorption in pregnant women, and determine if the plasma concentration of ritidrine is proportional to the dose administered in non-preterm women.
17
Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients.
Ashok Jain,Raman Venkataramanan,Rajeev Sharma,Tai Kwong,Mark S. Orloff,Peter L. Abt,Randeep Kashyap,Georgious Tsoulfas,Pam Batzold,Mary A. Williamson,Adel Bozorgzadeh +10 more
TL;DR: An initial tacrolimus dose reduction of about 30–40% may be prudent in LDLT compared with DDLT recipients, and although not statistically significant, the dose normalized AUC was 37.7% greater and clearance 47.5% lower in HDLT as compared withDDLT.
Stability and availability of cyclosporine in 5% dextrose injection or 0.9% sodium chloride injection
TL;DR: The stability of cyclosporine in commonly used i.v. solutions and the percentage of the drug delivered via polyvinyl chloride administration tubing were studied, and the potential for leaching of plasticizers was studied.
17
Metabolism of Tocainide in the Rat
TL;DR: The metabolism of tocainide, an oral antiarrhythmic agent, was studied in male Wistar rats following oral administration of 15 mg/kg of toCainide hydrochloride and metabolites in urine were identified.
17
Mycophenolic Acid for Topical Immunosuppression in Vascularized Composite Allotransplantation: Optimizing Formulation and Preliminary Evaluation of Bioavailability and Pharmacokinetics.
Firuz G. Feturi,Matthias Weinstock,Wenchen Zhao,Wei Zhang,Jonas T. Schnider,Vasil E. Erbas,Sinan Oksuz,Jan A. Plock,Lisa C. Rohan,Alexander M. Spiess,Lydia Masako Ferreira,Mario G. Solari,Raman Venkataramanan,Vijay S. Gorantla,Vijay S. Gorantla +14 more
TL;DR: This study successfully developed for the first time, a topical formulation of MPA in Lipoderm with optimal in vitro/in vivo permeability characteristics and no undesirable local or systemic adverse effects in vivo.